» Authors » Benson Musinguzi

Benson Musinguzi

Explore the profile of Benson Musinguzi including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 12
Citations 16
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Mwesigwa A, Golumbeanu M, Jones S, Cantoreggi S, Musinguzi B, Nankabirwa J, et al.
Sci Rep . 2025 Feb; 15(1):4375. PMID: 39910229
Antimalarial therapeutic efficacy studies are vital for monitoring drug efficacy in malaria-endemic regions. The WHO recommends genotyping polymorphic markers including msp-1, msp-2, and glurp for distinguishing recrudescences from reinfections. Recently,...
2.
Achan B, Musinguzi B, Itabangi H, Sande O, Meya D
IJID Reg . 2025 Feb; 14:100562. PMID: 39895834
Objectives: Postgraduate medical mycology research may also be affected by funding. This study reports the positive impact of funding on postgraduate medical mycology research at Makerere University, Uganda. Methods: This...
3.
Mwesigwa A, Kiwuwa S, Musinguzi B, Kawalya H, Katumba J, Baguma A, et al.
Trop Med Health . 2024 Dec; 52(1):103. PMID: 39734236
Background: Malaria is a significant public health challenge in Uganda, with Plasmodium falciparum (P. falciparum) responsible for most of malaria infections. The high genetic diversity and multiplicity of infection (MOI)...
4.
Musinguzi B, Akampurira A, Derick H, Turyamuhika L, Mwesigwa A, Mwebesa E, et al.
Microb Pathog . 2024 Dec; 199():107232. PMID: 39675440
Background: Commensal oral Candida species can become opportunistic and transition to pathogenic causes of oropharyngeal candidiasis (OPC) in individuals with impaired immunity through ecological cues and the expression of extracellular...
5.
Musinguzi B, Obuku E, Mwesigwa A, Migisha R, Kinengyere A, Ndagire R, et al.
Trop Med Health . 2024 Nov; 52(1):88. PMID: 39593167
Background: The introduction of antiretroviral therapy (ART) and the implementation of the human immunodeficiency virus (HIV) universal test and treat (UTT) policy have led to a decline in the incidence...
6.
Mwesigwa A, Ocan M, Cummings B, Musinguzi B, Kiyaga S, Kiwuwa S, et al.
Trop Med Health . 2024 Nov; 52(1):86. PMID: 39543779
Background: Plasmodium falciparum (P. falciparum) remains a significant public health challenge globally, especially in sub-Saharan Africa (SSA), where it accounts for 99% of all malaria infections. The outcomes of P....
7.
Musinguzi B, Obuku E, Kinengyere A, Ndagire R, Baguma A, Mwesigwa A, et al.
Res Sq . 2024 Jun; PMID: 38883750
Background: The incidence of oropharyngeal candidiasis among people living with human immunodeficiency virus in Africa is on the rise. Oropharyngeal candidiasis is mainly caused by ; however, a shift in...
8.
Musinguzi B, Akampurira A, Derick H, Mwesigwa A, Mwebesa E, Mwesigye V, et al.
Res Sq . 2024 May; PMID: 38766148
Background: Oropharyngeal species are part commensal microflora in the the oral cavity of health individuals. Commensal species can become opportunist and transition to pathogenic causes of oropharyngeal candidiasis (OPC) in...
9.
Mwesigye V, Musinguzi B, Okongo B, Mucunguzi W, Kakaire M, Migisha R
BMC Res Notes . 2024 May; 17(1):141. PMID: 38760672
Objective: Given the neglected nature of filariasis, especially in Uganda where data are scarce, this cross-sectional study aimed to determine the sero-antigen prevalence of lymphatic filariasis and risk factors associated...
10.
Mwesigwa A, Ocan M, Musinguzi B, Nante R, Nankabirwa J, Kiwuwa S, et al.
Malar J . 2024 Apr; 23(1):97. PMID: 38589874
Background: In sub-Saharan Africa (SSA), Plasmodium falciparum causes most of the malaria cases. Despite its crucial roles in disease severity and drug resistance, comprehensive data on Plasmodium falciparum genetic diversity...